All Diagnostics articles – Page 6
-
Research
Simple sensor can spot cancer markers in minutes
Test can rapidly detect mutant tumour nucleic acids in boost for personalised medicine
-
ResearchSilicon chip spots dangerous pathogens in human blood
Silicon wafer doped with silver nanoparticles can rapidly identify E. coli in blood
-
Research
DNA test colours in BRCA1 gene
Rolling circle amplification aids femtomolar sensitivity for gene linked with breast cancer
-
Research
Silver lining for paper Ebola test
Lateral flow test checks for Ebola, yellow fever and dengue in one go
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Research
Aptamers and gold nanoparticles whisked up to spot influenza
Gold-coated flu viruses sink in visual bioassay
-
Podcast
Chemistry World podcast - November 2014
We speak to Eric Betzig about his Nobel prize-winning research, and find out how thermoelectric materials can be made more efficient
-
Feature
Faster, cheaper, better diagnostics
Microfluidics researchers are aiming to bring new diagnostic devices into mainstream medicine. Mark Peplow reports
-
Research
CPU heat powers PCR disease detection
Computer and mobile phone combo detects Chagas disease in blood and could drive down diagnosis costs
-
Research
Urine test could catch lung cancer early
Cancer diagnosis could be accelerated using an approach that is low cost, rapid and non-invasive
-
Podcast
Chemistry World podcast - September 2014
We speak to Paul Clarke about the challenges of natural product synthesis and discuss the pros and cons of perovskite solar cells
-
-
Research
Molecular computer calculates Ebola diagnosis
A prototype device displays a fluorescent ‘E’ in the presence of DNA found in Ebola virus
-
Research
Organ–organ interactions could compound nanoparticle damage
Dual-organ simulation uncovers possible toxicity mechanisms that result in liver injury
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
